Trade Summary

1 week ago, Knight Jeff E., serving as Chief Dev., Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 85,163 shares at $40.10 per share, for a total transaction value of $3,415,036.00. Following this transaction, Knight Jeff E. now holds 105,289 shares of CRNX.

This sale represents a 45.00% decrease in Knight Jeff E.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 8, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 10, 2026, 2 days after the trade was made.

Crinetics Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.